Your browser doesn't support javascript.
loading
Burning mouth syndrome: Clinical description, pathophysiological approach, and a new therapeutic option. / Síndrome de boca ardiente: descripción clínica, planteamiento fisiopatológico y una nueva opción terapéutica.
Cárcamo Fonfría, A; Gómez-Vicente, L; Pedraza, M I; Cuadrado-Pérez, M L; Guerrero Peral, A L; Porta-Etessam, J.
Afiliação
  • Cárcamo Fonfría A; Servicio de Neurología, Hospital Universitario Fundación Jiménez Díaz, Madrid, España. Electronic address: albacarcamof@gmail.com.
  • Gómez-Vicente L; Servicio de Neurología, Hospital Universitario Clínico San Carlos, Madrid, España.
  • Pedraza MI; Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, España.
  • Cuadrado-Pérez ML; Servicio de Neurología, Hospital Universitario Clínico San Carlos, Madrid, España.
  • Guerrero Peral AL; Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, España.
  • Porta-Etessam J; Servicio de Neurología, Hospital Universitario Clínico San Carlos, Madrid, España.
Neurologia ; 32(4): 219-223, 2017 May.
Article em En, Es | MEDLINE | ID: mdl-26778734
ABSTRACT

INTRODUCTION:

Burning mouth syndrome is defined as scorching sensation in the mouth in the absence of any local lesions or systemic disease that would explain that complaint. The condition responds poorly to commonly used treatments and it may become very disabling.

METHODS:

We prospectively analysed the clinical and demographic characteristics and response to treatment in 6 cases of burning mouth syndrome, diagnosed at 2 tertiary hospital headache units.

RESULTS:

Six female patients between the ages of 34 and 82 years reported symptoms compatible with burning mouth syndrome. In 5 of them, burning worsened at the end of the day; 4 reported symptom relief with tongue movements. Neurological examinations and laboratory findings were normal in all patients and their dental examinations revealed no buccal lesions. Each patient had previously received conventional treatments without amelioration. Pramipexol was initiated in doses between 0.36mg and 1.05mg per day, resulting in clear improvement of symptoms in all cases, a situation which continues after a 4-year follow up period.

CONCLUSIONS:

Burning mouth syndrome is a condition of unknown aetiology that shares certain clinical patterns and treatment responses with restless leg syndrome. Dopamine agonists should be regarded as first line treatment for this entity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Ardência Bucal / Agonistas de Dopamina / Benzotiazóis Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En / Es Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Ardência Bucal / Agonistas de Dopamina / Benzotiazóis Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En / Es Ano de publicação: 2017 Tipo de documento: Article